These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 26999489)

  • 1. Metabolic syndrome and hypogonadism--two peas in a pod.
    Ebrahimi F; Christ-Crain M
    Swiss Med Wkly; 2016; 146():w14283. PubMed ID: 26999489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Testosterone deficiency, metabolic syndrome and diabetes mellitus].
    Fernández-Miró M; Chillarón JJ; Pedro-Botet J
    Med Clin (Barc); 2016 Jan; 146(2):69-73. PubMed ID: 26433309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Male hypogonadism and civilization diseases].
    Stárka L
    Cas Lek Cesk; 2012; 151(2):69-72. PubMed ID: 22515012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dark side of testosterone deficiency: I. Metabolic syndrome and erectile dysfunction.
    Traish AM; Guay A; Feeley R; Saad F
    J Androl; 2009; 30(1):10-22. PubMed ID: 18641413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence, Pathophysiology, and Management of Androgen Deficiency in Men with Metabolic Syndrome, Type 2 Diabetes Mellitus, or Both.
    Taylor SR; Meadowcraft LM; Williamson B
    Pharmacotherapy; 2015 Aug; 35(8):780-92. PubMed ID: 26289308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MYTHS AND CONTROVERSIES IN HYPOGONADISM TREATMENT OF AGING MALES.
    Ungureanu MC; Costache II; Preda C; Mogoş V; Vulpoi C; Leuştean L
    Rev Med Chir Soc Med Nat Iasi; 2015; 119(2):325-33. PubMed ID: 26204632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of testosterone undecanoate on cardiovascular risk factors and atherosclerosis in middle-aged men with late-onset hypogonadism and metabolic syndrome: results from a 24-month, randomized, double-blind, placebo-controlled study.
    Aversa A; Bruzziches R; Francomano D; Rosano G; Isidori AM; Lenzi A; Spera G
    J Sex Med; 2010 Oct; 7(10):3495-503. PubMed ID: 20646185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Androgen deficiency, diabetes, and the metabolic syndrome in men.
    Kalyani RR; Dobs AS
    Curr Opin Endocrinol Diabetes Obes; 2007 Jun; 14(3):226-34. PubMed ID: 17940444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baseline data from the TRiUS registry: symptoms and comorbidities of testosterone deficiency.
    Miner MM; Khera M; Bhattacharya RK; Blick G; Kushner H
    Postgrad Med; 2011 May; 123(3):17-27. PubMed ID: 21566412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic Effects of Testosterone Therapy in Men with Type 2 Diabetes and Metabolic Syndrome.
    Hackett G
    Sex Med Rev; 2019 Jul; 7(3):476-490. PubMed ID: 30803918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testosterone deficiency.
    Traish AM; Miner MM; Morgentaler A; Zitzmann M
    Am J Med; 2011 Jul; 124(7):578-87. PubMed ID: 21683825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The emerging link between hypogonadism and metabolic syndrome.
    Guay AT
    J Androl; 2009; 30(4):370-6. PubMed ID: 18772486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The complex association between metabolic syndrome and male hypogonadism.
    Dimopoulou C; Goulis DG; Corona G; Maggi M
    Metabolism; 2018 Sep; 86():61-68. PubMed ID: 29656047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Late-onset hypogonadism: metabolic impact.
    Grossmann M; Ng Tang Fui M; Cheung AS
    Andrology; 2020 Nov; 8(6):1519-1529. PubMed ID: 31502758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testosterone deficiency in men with Type 2 diabetes: pathophysiology and treatment.
    Gianatti EJ; Grossmann M
    Diabet Med; 2020 Feb; 37(2):174-186. PubMed ID: 31006133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Body composition, metabolic syndrome and type 2 diabetes in Klinefelter syndrome.
    Gravholt CH; Jensen AS; Høst C; Bojesen A
    Acta Paediatr; 2011 Jun; 100(6):871-7. PubMed ID: 21342256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testosterone therapy improves the clinical response to conventional treatment for male patients with metabolic syndrome associated to late onset hypogonadism.
    La Vignera S; Calogero AE; D'Agata R; Di Mauro M; Tumino S; Condorelli R; Lanzafame F; Finocchiaro C; Giammusso B; Vicari E
    Minerva Endocrinol; 2008 Sep; 33(3):159-67. PubMed ID: 18846023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testosterone replacement in men.
    Beg S; Al-Khoury L; Cunningham GR
    Curr Opin Endocrinol Diabetes Obes; 2008 Aug; 15(4):364-70. PubMed ID: 18594278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testosterone deficiency and risk factors in the metabolic syndrome: implications for erectile dysfunction.
    Guay AT; Traish A
    Urol Clin North Am; 2011 May; 38(2):175-83. PubMed ID: 21621084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testosterone replacement therapy in obese males.
    Drewa T; Olszewska-Słonina D; Chlosta P
    Acta Pol Pharm; 2011; 68(5):623-7. PubMed ID: 21928705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.